Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. CPHI
CPHI logo

CPHI Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
0.616
Open
0.598
VWAP
0.59
Vol
34.68K
Mkt Cap
3.01M
Low
0.550
Amount
20.61K
EV/EBITDA(TTM)
--
Total Shares
5.02M
EV
6.11M
EV/OCF(TTM)
26.03
P/S(TTM)
0.36
China Pharma Holdings Inc is a company principally engaged in the development, manufacture, and marketing of pharmaceutical products for human use. The Company is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. The Company's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The Company's products and solutions are mainly applied in the treatment of various diseases and medical conditions. The Company mainly operates in the domestic market.
Show More

Events Timeline

(ET)
2025-04-04
16:06:13
China Pharma announces 1-for-10 reverse stock split
select
2024-12-13 (ET)
2024-12-13
07:03:25
China Pharma announces $600,000 common stock offering
select

News

Benzinga
9.5
2025-11-25Benzinga
Keysight Shares Rise Approximately 15%; Check Out 20 Stocks Making Moves in Premarket Trading
  • Keysight Technologies Earnings Report: Keysight Technologies Inc. reported fourth-quarter earnings of $1.91 per share and revenue of $1.42 billion, surpassing analyst expectations, leading to a 14.8% increase in share price during pre-market trading.

  • Other Notable Gainers: Several stocks saw significant pre-market gains, including Icon Energy Corp (+33.4%), WeShop Holdings Limited (+23.1%), and Inno Holdings Inc (+23%), following positive trading sessions.

  • Stocks Experiencing Losses: MingZhu Logistics Holdings Ltd led the decliners with a 15.8% drop, alongside other companies like Prestige Wealth Inc (-11.2%) and Pasithea Therapeutics Corp (-11.1%) after previous gains.

  • Market Overview: The article provides a snapshot of various stocks' performances in pre-market trading, highlighting both gainers and losers, along with specific financial results that influenced these movements.

NASDAQ.COM
2.0
2025-07-03NASDAQ.COM
What Is a 1‑for‑10 Reverse Stock Split?
  • Banzai International's Reverse Stock Split: Banzai International, Inc. announced a 1-for-10 reverse stock split effective July 8, 2025, aimed at boosting its share price to meet Nasdaq listing requirements and improve market perception.

  • Industry Trends in Reverse Splits: The move aligns with a trend among small-cap companies like Comstock Inc. and Arrowhead Pharmaceuticals, which have also implemented reverse splits recently to address compliance issues and enhance appeal to institutional investors.

Benzinga
4.5
2025-04-07Benzinga
Crude Oil Down 2%; Chanson International Shares Spike Higher
  • Market Performance: U.S. stocks experienced a significant decline, with the Dow Jones dropping over 800 points, while European and Asian markets also closed lower amid economic concerns and tariff tensions between the U.S. and China.

  • Notable Stock Movements: Janover Inc. saw a remarkable 332% increase in shares after raising funds, while TAL Education Group and China Pharma Holdings faced substantial declines due to tariffs and stock splits, respectively.

Benzinga
4.5
2025-04-07Benzinga
Nasdaq Surges Over 400 Points; China Pharma Shares Plummet
  • U.S. Stock Market Performance: U.S. stocks rose significantly, with the Nasdaq Composite gaining over 400 points and sectors like information technology seeing a 4.7% increase, while European and Asian markets experienced declines.

  • Equities Movement: Notable stock movements included Janover Inc. surging 331% after raising funds, while Antelope Enterprise Holdings saw a 44% drop due to a reverse stock split; commodities like oil and silver also showed gains.

Benzinga
4.5
2025-04-07Benzinga
US Stock Futures Slump Following Massive Tariff-Induced Selloff: Experts Warn Of A Brewing 'Great Depression-Like' Pattern
  • Market Decline: U.S. stock futures dropped sharply, with major indices like the S&P 500 nearing bear market territory due to intensified selloffs following China's retaliatory tariffs against U.S. measures. The S&P 500 recorded its worst weekly decline since March 2020.

  • Economic Outlook: Analysts express concern over the lack of support from the Federal Reserve or government interventions, predicting further market downturns unless significant instability occurs in the Treasury market. Despite this, some strategists encourage buying amid the current sentiment.

Benzinga
4.5
2025-04-07Benzinga
US Stock Futures Drop Following Massive Tariff-Induced Selloff: Experts Warn Of A Brewing 'Great Depression-Like' Pattern
  • Market Decline: U.S. stock futures dropped sharply, with major indices like the S&P 500 and Nasdaq 100 nearing bear market territory due to escalating tensions from China's tariff retaliation against the U.S., leading to significant losses over the past week.

  • Economic Indicators: Despite strong job growth reported in March, rising unemployment and a lack of confidence in Federal Reserve intervention have contributed to market uncertainty, prompting analysts to warn of potential further declines reminiscent of historical downturns.

Valuation Metrics

The current forward P/E ratio for China Pharma Holdings Inc (CPHI.A) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess China Pharma Holdings Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Whales Holding CPHI

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is China Pharma Holdings Inc (CPHI) stock price today?

The current price of CPHI is 0.616217 USD — it has increased 2.84

What is China Pharma Holdings Inc (CPHI)'s business?

China Pharma Holdings Inc is a company principally engaged in the development, manufacture, and marketing of pharmaceutical products for human use. The Company is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. The Company's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The Company's products and solutions are mainly applied in the treatment of various diseases and medical conditions. The Company mainly operates in the domestic market.

What is the price predicton of CPHI Stock?

Wall Street analysts forecast CPHI stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CPHI is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is China Pharma Holdings Inc (CPHI)'s revenue for the last quarter?

China Pharma Holdings Inc revenue for the last quarter amounts to 756.22K USD, decreased -31.26

What is China Pharma Holdings Inc (CPHI)'s earnings per share (EPS) for the last quarter?

China Pharma Holdings Inc. EPS for the last quarter amounts to -0.17 USD, decreased -73.85

How many employees does China Pharma Holdings Inc (CPHI). have?

China Pharma Holdings Inc (CPHI) has 224 emplpoyees as of March 10 2026.

What is China Pharma Holdings Inc (CPHI) market cap?

Today CPHI has the market capitalization of 3.01M USD.